Working Sheet Related to Price Notified on 15th

Transcription

http://www.nppaindia.nic.in/ceiling/press15sept14/workingsheet-15-9-14.html
NLEM
Molecule_Desc
Market
PACK_DESC
BRANDS
18.3.2
18.3.2
IUD-COPPER WIRE
IUD-COPPER WIRE
IUD-COPPER WIRE
IUD-COPPER WIRE
IUD-COPPER WIRE
IUD-COPPER WIRE
IUD containing Copper
MULTILOAD CU 250 IUD x 1
MULTILOAD CU 375 IUD x 1
T care 200B
T Care 380A
M care Cu 250
N care Cu 375
MULTILOAD
MULTILOAD
T care 200B
T Care 380A
M care Cu 25
N care Cu 37
Unit
COMPANY
MAT May'12
Value
1Organon (I
1Organon (I)
1HLL Lifecar
1HLL Lifecar
1HLL Lifeca
1HLL Lifecar
Total
PTR May'12
44729595
25861337
225985
341147
2058797
810725
74027586
MAT %
PTR per unit
320.00
481.60
96.00
100.00
280.00
432.00
60.42
34.93
0.31
0.46
2.78
1.10
100.00
maximum
As per the above there are 2 companies consisting of Market Share of 1% & Above
Sum of MAT value considered for price calculation
Sum of PTR per unit considered for price calculation
Number of Packs considered
Average PTR
Add : 16% Retailer Margin
Ceiling Price (without local taxes)
% Reduction with compared to Highest Price
320.00
481.60
96.00
100.00
280.00
432.00
284.93
481.60 minimum
Ceiling
Price with
16%
Margin
330.52
96.00
740.28(Rs. in lakhs)
1709.60
6.00
284.93
45.59
330.52
40.84%
6.32%
351.41 S.O. 2349(E) dt. 15.9.2014
WPI increase on 1 April, 2014
Ceiling Price after WPI Adjustment
NLEM
Molecule_Desc
19.3.1.1
VACCINE, BACILLUS CALMETTE-GUERIN
B.C.G Vaccine Injection
Market
BCG VACCINE
PACK_DESC
BCG VACCINE
BRANDS
SERUM INS
COMPANY
VACCINE, BACILLUS CALMETTE-GUERIN
B.C.G Vaccine Injection
BCG INJ DRY V
BCG
UNIDENT MA
No. of Doses
MAT May'12 Value
10
83.35
23661
23.22
5
83362661
Total
Monopoly situation as only M/s. Se
PTR per unit
Price fixed in the relevant sub-secti
PTR May'12
83339000
PTR per
dose
MAT %
29763928.57
8450.36
29772378.93
8.34
4.64
8.34
8.34
19.3.1: For Universal Immunisation
Drugs
Category
Route of Administration/
Dosage Form
Strengths
B.C.G Vaccine
P,S,T
Injection
Not mentioned
Meeting No.
S.No.
Under consideration
D.P.T Vaccine
P,S,T
Injection
Not mentioned
232.86
1st
Hepatitis B Vaccine
P,S,T
Injection
Not mentioned
101.09
8th
Measles Vaccine
P,S,T
Injection
Not mentioned
252.97
8th
Oral Poliomyelitis vaccine (LA)
P,S,T
Solution
99.9
10th
Not mentioned
Therefore, PTR per unit
Add: 16% Retailer Margin
Ceiling Price per unit
WPI @ 6.32%
Ceiling price with WPI
ENALAPRI
% Reduction w.r.
t. Highest Price
Date
Unit Ceiling Price
1
2
3
4
5
Molecule
S.O.No.
8.34 x(1-45.64%)
Market
PACK_DESC
BRANDS
MANUFACTUR
COMPANY
Enalapril Maleate Injection 1.25 mg/ml
ENVAS INJ AMP 1.25 MG 1 ML x 1 (/1ML)
ENVAS
CADILA PHARM
CADILA PHARMA
Monopoly situation as only M/s. Cadila Pharma
PTR per unit
Price fixed in the relevant sub-section for oth
167114.06.2013
335105.11.2013
335205.11.2013
3374 (E)
20.12.2013
Average
4.53
0.72
5.25
0.33
5.58 per dose
MAT May'1
47.67
78.15
44.53
12.21
45.64
S.O. 2356(E) dt. 15.9.2014
PTR May'12
11881948
167.86
167.86
12.3: Anti hypertensive medicines
S.No.
12.3.3
12.3.3
12.3.3
Drugs
Category
Route of Administration/ Dosage Form
Strengths
Enalpril Maleate
P,S,T
Enalpril Maleate
P,S,T
Tablets
Tablets
2.5 mg
5 mg
Enalpril Maleate
T
Injection
1.25mg/ml
Meeting No.
Unit Ceiling Price
1.78
2.96
S.O.No.
Date
163314.06.2013
163414.06.2013
1st
1st
6.75
14.33
Under consideration
Average
% Reduction w.r.t.
Highest Price
167.86x(1-10.54%)
10.54
150.17
WPI @ 6.32%
24.03
174.20
11.01
185.21S.O. 2357(E) dt. 15.9.2014
NLEM Un
24.1.0.2
24.1.0.2
24.1.0.2
Composition as per NLEM
Chlorpromazine hydrochloride Tablets 50 mg
PACK_DESC
CHLORPROMAZINE TABS 50 MG x 10
CPZ FILM C.TABS 50 MG x 10
EMETIL TABS 50 MG x 10
http://www.nppaindia.nic.in/ceiling/press15sept14/workingsheet-15-9-14.html (1 of 16)9/23/2014 3:52:48 PM
BRANDS
CHLORPROMAZINE
CPZ
EMETIL
MANUFACTU
SUN*
A.N.PHARMA
LA PHARMA
65.63(Rs. In Lakhs)
1.02
3
Strength
Unit
50
50
50
Unit
10per tablet
10per tablet
10per tablet
MAT Sep'13 Value MAT%
PTR Sep'13
1712751
396470.14%
3.36
3617119
837296.06%
3.36
1233262
285477.31%
3.43
6563132
1519243.52%
maximum
0.34 minimum
Ceiling
Price per Price with
Unit
16% Margin
0.34
0.34
0.34
0.34
0.39
0.34
Average PTR
0.34
0.05
0.39
0.00%
6.32%
0.41 S.O. 2351(E) dt. 15.9.2014
NLEM
Unique
No.
PACK_DESC
BRANDS
Company
24.1.0. Chlorpromazine hydrochloride Tablets 1
CHLORPROMAZINE TABS 100 MG x 10
CPZ FILM C.TABS 100 MG x 10
EMETIL TABS 100 MG x 10
CHLORPROMAZINE
CPZ
EMETIL
SUN*
A.N.PHARM
LA PHARM
As per the above there are 3 companies consi
Sum of MAT value considered for price calculat
Sum of PTR per unit considered for price calcul
Average PTR
Unit
100
100
100
MAT Sep'13
Value
Unit
10per tablet
10per tablet
10per tablet
MAT%
2839149
3122847
1345939
7307935
maximum
PTR Sep'13
5.48
38.85
5.48
42.73
5.45
18.42
100.00
0.55 minimum
Ceiling
Price
Price
with
per Unit
16%
Margin
0.55
0.55
0.55
0.55
0.55
73.08 (Rs. In Lak
1.65
3
0.55
0.09
0.64
0.00%
6.32%
0.68 S.O. 2351(E)
S.No.
Formulation
1 Ciprofloxacin Hydrochloride Tablets 250 mg (Coat
4 Ciprofloxacin Hydrochloride Tablets 250 mg (Coated)
Strength
PACK_DESC
Pack size
BRANDS
COMPANY
MAT Sep'13 Value
PTR Sep'13
MAT %
FLOXIP FILM C.TABS 250 MG x 10
10FLOXIP
ABBOTT*
5566785
CIPROWIN FILM C.TABS 250 MG x 10
10CIPROWIN
ALEMBIC
18322245
10.50
STROX FILM C.TABS 250 MG x 10
10STROX
ALEMBIC
8623045
10.50
BAYCIP FILM C.TABS 250 MG x 10
10BAYCIP
BAYER ZYDUS PHARMA
CEBRAN FILM C.TABS 250 MG x 10
10CEBRAN
CIPRODAC FILM C.TABS 250 MG x 10
10CIPRODAC
CIPLOX FILM C.TABS 250 MG x 10
10CIPLOX
CIPLA
CIPROLET FILM C.TABS 250 MG x 10
10CIPROLET
DR REDDYS LABS
ZOXAN FILM C.TABS 250 MG x 10
10ZOXAN
FDC
CIPRIND FILM C.TABS 250 MG x 10
10CIPRIND
INDOCO*
CIFLOX FILM C.TABS 250 MG x 10
10CIFLOX
IND-SWIFT
3084930
9.68
SWIFLOX FILM C.TABS 250 MG x 10
10SWIFLOX
IND-SWIFT
3714784
11.26
CIPROLAR FILM C.TABS 250 MG x 10
10CIPROLAR
LARK LABS
CIPROVA FILM C.TABS 250 MG x 10
10CIPROVA
LUPIN LIMITED
LUCIPRO FILM C.TABS 250 MG x 10
10LUCIPRO
LUPIN LIMITED
MAFLO FILM C.TABS 250 MG x 10
10MAFLO
MAPRA LABS
MICROFLOX FILM C.TABS 250 MG x 10
10MICROFLOX
MICRO LABS*
CIFRAN FILM C.TABS 250 MG x 10
10CIFRAN
RANBAXY*
CIPBID FILM C.TABS 250 MG x 10
10CIPBID
SHREYA LIFE SCIENC
QUINTOR FILM C.TABS 250 MG x 10
10QUINTOR
TORRENT PHARMA
CIPBACT FILM C.TABS 250 MG x 10
10CIPBACT
UNICHEM*
695527
8.22
CIPROTAB FILM C.TABS 250 MG x 10
10CIPROTAB
WOCKHARDT LTD*
728981
13.50
BIOBID FILM C.TABS 250 MG x 10
10BIOBID
ZYDUS CADILA*
84687
12.00
BIOCIP FILM C.TABS 250 MG x 10
10BIOCIP
ZYDUS CADILA*
1132446
26.36
GERCIP FILM C.TABS 250 MG x 10
10GERCIP
ZYDUS CADILA*
89400
7.40
2756036
26.21
BLUE CROSS
7532922
25.56
CADILA PHARMA
3676060
9.25
85237149
28.60
1422802
26.53
16871490
23.16
421804
22.56
271039
24.87
2907993
10.10
85934
8.10
408035
21.53
12267906
25.51
113687607
28.60
4764092
10.80
3964087
25.39
298317786
0.85
1.05
1.05
2.62
2.56
0.93
2.86
2.65
2.32
2.26
0.97
1.13
2.49
1.01
0.81
2.15
2.55
2.86
1.08
2.54
0.82
1.35
1.2
2.64
0.74
Average
1.90
1.64
0.81
2.86 Minimum
Maximum
Retailer
Margin@16%
PTR
1.87
6.14
2.89
0.92
2.53
1.23
28.57
0.48
5.66
0.14
1.03
1.25
0.09
0.97
0.03
0.14
4.11
38.11
1.60
1.33
0.23
0.24
0.03
0.38
0.03
8.50
As per above, there are 12 companies having Market share of 1% and above
24.57
15
1.64
0.26
1.90
42.66%
Average PTR
Ceiling Price (without taxes)
6.32%
2.02 S.O. 2352(E) dt. 15.9.2014
WPI increase on 1 April 2014
NLEM
1 6.2.2.3
2 6.2.2.3
3 6.2.2.3
4 6.2.2.3
5 6.2.2.3
6 6.2.2.3
7 6.2.2.3
8 6.2.2.3
9 6.2.2.3
10 6.2.2.3
11 6.2.2.3
12 6.2.2.3
13 6.2.2.3
(Rs. in Lakhs)
2,903.07
Molecule_Desc
Market
PACK_DESC
BRANDS
CIPROFLOXACIN HYDROCHLORIDE
Ciprofloxacin Hydrochloride Tablets 500 mg
FLOXIP FILM
FLOXIP
10ABBOTT*
CIFOMED TABS
CIFOMED
10AGLOWMED
CIPROWIN FIL
CIPROWIN
10ALEMBIC
STROX FILM C.
STROX
ALCIPRO FILM
ALCIPRO
LOXY TABS 50
LOXY
10ALKEM*
BAYCIP FILM
BAYCIP
10BAYER ZYDUS PHA
QUFLOX FILM C
QUFLOX
10BECKCEM
XIPRO TABS 50
XIPRO
10BLISS
CEBRAN FILM
CEBRAN
10BLUE CROSS
CIPRODAC FIL
CIPRODAC
10CADILA PHARMA
CIPLOX FILM
CIPLOX
10CIPLA
CIPTEC TABS
CIPTEC
10CIPLA
Pack size
COMPANY
MAT Sep'13 Value
PTR Sep'13
MAT %
19250643
16.00
18481947
49.44
24916794
19.00
10ALEMBIC
13126369
17.00
10ALKEM*
127000827
52.95
124609
19.68
24655505
50.80
45916
46.38
631954
41.58
31753006
44.66
27099845
17.50
417527787
55.00
303886
13.50
PTR per un
1.04%
0.99%
1.34%
0.71%
6.84%
0.01%
1.33%
0.00%
0.03%
1.71%
1.46%
22.47%
0.02%
1.60
4.94
1.90
1.70
5.30
1.97
5.08
4.64
4.16
4.47
1.75
5.50
1.35
0.64
14 6.2.2.3
15 6.2.2.3
16 6.2.2.3
17 6.2.2.3
18 6.2.2.3
19 6.2.2.3
20 6.2.2.3
21 6.2.2.3
22 6.2.2.3
23 6.2.2.3
24 6.2.2.3
25 6.2.2.3
26 6.2.2.3
27 6.2.2.3
28 6.2.2.3
29 6.2.2.3
30 6.2.2.3
31 6.2.2.3
32 6.2.2.3
33 6.2.2.3
34 6.2.2.3
35 6.2.2.3
36 6.2.2.3
37 6.2.2.3
38 6.2.2.3
39 6.2.2.3
40 6.2.2.3
41 6.2.2.3
42 6.2.2.3
43 6.2.2.3
44 6.2.2.3
45 6.2.2.3
46 6.2.2.3
47 6.2.2.3
NEOCIP TABS
NEOCIP
10CIPLA
CIPROLET FILM
CIPROLET
10DR REDDYS LABS
ECIP FILM C.TA
ECIP
10EAST WEST PHARMA
416660
10.11
15500858
52.01
358132
45.50
ZUCIPRO TABS
ZUCIPRO
10EMCURE*
ZOXAN FILM C
ZOXAN
10FDC
CIPRIND FILM
CIPRIND
10INDOCO*
SWIFLOX FILM
SWIFLOX
10IND-SWIFT
C-FLOX TABS 5
C-FLOX
10INTAS PHARMA*
CIPROTAS TAB
CIPROTAS
10INTAS PHARMA*
COUTIM FILM C
COUTIM
10JAGSON PAL
CEFLOX TABS 5
CEFLOX
10LABORATE PHARMA
CIPROLAR FILM
CIPROLAR
CIPROLEB FILM
CIPROLEB
CEEPRO TABS
CEEPRO
10LINCOLN PHARMA
2437029
51.32
CIPROLUP TAB
CIPROLUP
10LUPIN LIMITED
798570
21.00
CIPROVA FILM
CIPROVA
10LUPIN LIMITED
21370954
16.80
LUCIPRO FILM
LUCIPRO
10LUPIN LIMITED
162432
17.27
CIPROZOLE FI
CIPROZOLE
10MANKIND
26606539
46.00
MAFLO FILM C.T
MAFLO
10MAPRA LABS
3890959
45.22
CIPTAB TABS
CIPTAB
10MICRO LABS*
385390
18.00
MICROFLOX FI
MICROFLOX
10MICRO LABS*
76910063
49.44
ICIP TABS 500
ICIP
10NOEL PHARMA
951532
CIPROCURE FIL
CIPROCURE
10RADICURA PHARMA
243293
38.50
CIFRAN FILM
CIFRAN
10RANBAXY*
607671276
55.00
CIPRACT TABS
CIPRACT
10RANBAXY*
9538079
14.64
QUINTOR FIL
QUINTOR
10TORRENT PHARMA
28703717
49.21
CIPBACT FILM
CIPBACT
10UNICHEM*
367514
16.20
CIPROTAB FILM
CIPROTAB
10WOCKHARDT LTD*
7819661
17.95
CIPROSYN TAB
CIPROSYN
10WOCKHARDT LTD*
70171
CIPROZEN-F TA
CIPROZEN-F
10ZENITH LABS
BIOBID FILM
BIOBID
10ZYDUS CADILA*
BIOCIP FILM C
BIOCIP
CIPROBID FIL
CIPROBID
GERCIP FILM
GERCIP
73779
21.50
91771420
45.48
1347044
42.92
18328134
18.00
3537905
16.00
1543499
17.00
576504
18.50
6029304
16.00
10LARK LABS
134455
41.42
10LEBEN LABS
815039
32.26
20.80
16.00
329098
45.63
395991
15.21
10ZYDUS CADILA*
10299714
52.80
10ZYDUS CADILA*
213605318
52.53
10ZYDUS CADILA*
176029
12.00
1858085150
Maximum
5.50Minimum
(Rs. in la
17,745.71
78.16
25
3.13
0.50
3.63
43.09%
Average PTR
6.32%
3.86 S.O. 2352(E) dt. 15.9.2014
RIFAMPICIN 300MG TABLET
NLEM
6.2.3.3.2
SKU
MACOX 300 MG TABLET 6
MONOCIN 300 MG TABLET 10
RF 300 MG TABLET 10
Grand Total
COMPANY
Values
Pack
Sum of MAT UNIT SEPT 13
size
MACLEODS PHARMACEUTICALS PVT.LTD
OVERSEAS HEALTHCARE PVT LTD.
SUNIJ PHARMA PVT LTD
89475.0
6304.0
539.0
96318.0
Sum of MAT VALUE SEPT 13
6
10
10
MAT %
PTR
90.19%
8.95%
0.86%
100.00%
2.29
1386445.8
137510.1
13286.4
1537242.3
Maximum
PTR with Retailer
Margin@16%
PTR per tab
13.74
21.81
22.90
Average
Minimum
2.29
2.18
2.29
2.24
2.18
2.60
(Rs. in la
15.24
4.47
2
2.24
0.36
2.60
2.18%
Average PTR
6.32%
2.76 S.O. 2354(E) dt. 15.9.2014
NLEM
6.2.4.5
SKU
MONOCIN 450 MG TABLET 10
RF 450 MG TABLET 10
RIMACTANE 450 MG TABLET 4
Grand Total
COMPANY
OVERSEAS HEALTHCARE PVT LTD.
SUNIJ PHARMA PVT LTD
NOVARTIS INDIA LTD
Values
Pack
18721.0
229.0
2214.0
21164.0
size
10
10
4
Sum of MAT VALUE SEPT 13
591209.18
7685.63
36596.88
635491.69
Maximum
MAT %
PTR
93.03%
1.21%
5.76%
100.00%
3.35
(Rs. in la
6.35
9.86
Average
Minimum
PTR with Retailer
Margin@16%
PTR per tab
31.58
33.50
13.40
3.16
3.35
3.35
3.29
3.16
3.82
0.02%
0.83%
0.02%
0.00%
4.94%
0.07%
0.99%
0.19%
0.08%
0.03%
0.32%
0.01%
0.04%
0.13%
0.04%
1.15%
0.01%
1.43%
0.21%
0.02%
4.14%
0.05%
0.01%
32.70%
0.51%
1.54%
0.02%
0.42%
0.00%
0.02%
0.02%
0.55%
11.50%
0.01%
1.01
5.20
4.55
2.15
4.55
4.29
1.80
1.60
1.70
1.85
1.60
4.14
3.23
5.13
2.10
1.68
1.73
4.60
4.52
1.80
4.94
2.08
3.85
5.50
1.46
4.92
1.62
1.80
1.60
4.56
1.52
5.28
5.25
1.20
100.00%
3.13
1.01
3.63
3
3.29
0.53
3.82
1.79%
Average PTR
6.32%
4.06 S.O. 2354(E) dt. 15.9.2014
S.No.
Unique No. as per NLEM
16.0.1.2
Pack Size
Pack Description
BRANDS
Company
Strength
Furosemide Tablets 40mg
LASIX TAB UNCOATED 40 MG x 15
LASIX
SANOFI*
40
15TABS
Furosemide Tablets 40mg
Frusenex 40mg Tablet
Frusenex 40mg
Geno Pharmaceuticals
40
10TABS
MAT Value as on
30th Sept. 2013
Unit
MAT %
Price per
Unit
PTR
99.95%
5.46
44062
0.05%
3.5
97809630
100.00%
97765568
0.36
0.35Pharma track
Monopoly situation as M/s Sanofi is the only company manufacturing the formulation and has market share of 100%
PTR per unit
0.36
Price fixed in the relevant sub-section for other drugs is as follows:
Section: 16 –Diuretics
Medicines
Category
Furosemide
P,S,T
Route of Admn
Injection
MRP excl. local
taxes (Rs./unit)
Strengths
10 mg/ ml
Meeting No.
S.O No
% Reduction w.r.
t. Highest Price
Date
25.93%
To be consi
Furosemide
P,S,T
Tablets
40mg
Under con
Hydrochlorothiazide
P,S,T
Tablets
25 mg
1.66
Hydrochlorothiazide
P,S,T
Tablets
50 mg
Data Not Available
Mannitol
P,S,T
Injection
10%
Mannitol
P,S,T
Injection
20%
Spironolactone
P,S,T
Tablets
25 mg
1st
1640
14.6.2013
0.23
9th
3572(E)
02.12.2013
2.50%
0.35
4th
2062
05.07.2013
54.50%
20.78%
25.93%
To be consi
Average % Reduction
S.No.
0.36 X (1-25.93%)
0.27
0.04
0.31
0.02
0.33 S.O. 2360(E) dt. 15.9.2014
16.0.1.1
Pack Size
Furosemide Injection 10 mg/ ml
25.93%
Pack Description
LASIX INJ AMP 10 MG 2 ML x 1 (/1ML)
BRANDS
LASIX
Company
SANOFI*
Strength
10mg
Strengths
Ceiling price excl.
local taxes (Rs./
unit)
Meeting No.
MAT Value as on
30th Sept. 2013
Unit
2ML
77654065
77654065
MAT %
PTR
100.00%
Monopoly situation as M/s Sanofi is the only company manufacturing the formulation and has market share of 100%
PTR per unit
1.23
Medicines
Category
Route of Admn
Furosemide
P,S,T
Injection
10 mg/ ml
Under con
Furosemide
P,S,T
Tablets
40mg
Hydrochlorothiazide
P,S,T
Tablets
25 mg
To be consi
1.66
Hydrochlorothiazide
P,S,T
Tablets
50 mg
Data Not Available
Mannitol
P,S,T
Injection
10%
Mannitol
P,S,T
Injection
20%
Spironolactone
P,S,T
Tablets
25 mg
S.O No
% Reduction w.
r.t. Highest
Price
Date
25.93%
1st
1640
14.6.2013
0.23
9th
3572(E)
02.12.2013
2.50%
0.35
4th
2062
05.07.2013
54.50%
25.93%
To be consi
Average %
Reduction
1.23 X (1-25.93%)
0.91
0.15
1.06
0.07
1.13 S.O. 2360(E) dt. 15.9.2014
Source
Pharma
SKU
COMPANY
R-CIN 150 MG TABLET 20
LUPIN LTD
2486.0
Sum of MAT VALUE SEPT Pack size
13
71099.6
PTR
20
PTR per unit
Price fixed in the relevant sub-section for other similar drugs is as follows:
PTR per tablet
24.4
Monopoly situation as only M/s. Lupin is the known manufacturer
1.22
20.78%
1.22
25.93%
2.46
Price per
Unit
1.23
1
2
3
4
Medicines
Category
Clofazimine
P,S,T
6.2.3:Antileprosy medicines
Unit Ceiling Price
Strengths
Meeting No.
S.O.No.
Date
1st
1581
14.06.2013
% Reduction w.r.t.
Highest Price
15.00
Capsules
50 mg
1.28
Clofazimine
Capsules
100 mg
2.22
1st
1582
14.06.2013
22.19
Dapsone
Tablets
50 mg
0.20
7th
2835 (E)
20.09.2013
18.60
Dapsone
Tablets
100 mg
0.22
7th
2836 (E)
20.09.2013
18.60
Average reduction
1.22 x(1-18.60%)
WPI @ 6.32%
S.No.
0.16
1.15
0.07
1.22 S.O. 2360(E) dt. 15.9.2014
16.0.1.4
18.60
0.99
Pack Size
Pack Description
BRANDS
Company
Spironolactone Tablets 25 mg
ALDACTONE TAB UNCOATED 25 MG x 15
ALDACTONE
RPG LIFE SCIENCES
Strength
MAT Value as on
30th Sept. 2013
Unit
25
15TABS
50111219
MAT %
50111219
Monopoly situation as M/s RPG Life Science is the only company manufacturing the formulation and has market share of 100%
PTR per unit
1.33
Medicines
Category
Route of Admn
Furosemide
P,S,T
Ceiling price excl.
local taxes (Rs./unit) Meeting No.
Strengths
Injection
S.O No
% Reduction w.r.
t. Highest Price
Date
25.93%
10 mg/ ml
To be consi
To be consi
1.66
1st
1640
9th
3572(E)
02.12.2013
2.50%
4th
2062
05.07.2013
54.50%
Furosemide
P,S,T
Tablets
40mg
Hydrochlorothiazide
P,S,T
Tablets
25 mg
Hydrochlorothiazide
P,S,T
Tablets
50 mg
Mannitol
P,S,T
Injection
10%
Data Not A
0.23
Mannitol
P,S,T
Injection
20%
0.35
Spironolactone
P,S,T
Tablets
25 mg
25.93%
14.6.2013
1.33 X (1-25.93%)
20.78%
Under con
Average %
Reduction
25.93%
0.99
0.16
1.15
0.07
1.22 S.O. 2360(E) dt. 15.9.2014
SULPHADIAZINE 500 MG TABLET
Values
Sum of MAT UNIT SEP 13 Sum of MAT VAUE SEPT 13
Source
SKU
COMPANY
Pharma data
SULPHADIAZINE 500 MG TABLET 10
Grand Total
ABOTT HEALTHCARE PVT. LTD.
PTR
214.0
214.0
2534.0
2534.0
Monopoly situation as only M/s. Abott is the k
PTR per unit
Drugs
S.No.
1 Amikacin
2 Azithromycin
3 Azithromycin
4 Azithromycin
5 Azithromycin
6 Azithromycin
7 Ciprofloxacin Hydrochloride
10 Co-Trimoxazole (Trimethoprim + Sulphamethoxazole)
13 Doxycycline
14 Erythromycin Estolate
17 Gentamicin
18 Gentamicin
19 Metronidazole
20 Metronidazole
21 Metronidazole
22 Metronidazole
23 Nitrofurantoin
24 Sulphadiazine
25 Vancomycin Hydrochloride
26 Vancomycin Hydrochloride
PTR per tablet
9.20
0.92
0.92
6.2.2 Othe antibacterials
Category
Unit Ceiling Price
Dosage Form
Strengths
Meeting No.
S.O.No.
S,T
Injection
250 mg/2 ml
13.96
2nd
S,T
Tablets
100 mg
5.13
S,T
Tablets
250 mg
4th
4th
8th
5th
1st
2051
2052
3379
2237
1578
1157 (E)
S,T
Tablets
500 mg
S,T
Suspension
100mg/5ml
S,T
Injection
500 mg
182.27
P,S,T
Injection
200 mg/100 ml
0.16
14th
P,S,T
Tablets
250 mg
1.90
To be considered in 18 th meeting
P,S,T
Tablets
500 mg
3.63
Tablets
21.6.2013
05.07.2013
05.07.2013
05.11.2013
22.07.2013
14.06.2013
28.04.2014
1801
10.26
20.51
1.55
P,S,T
Date
80+400 mg
0.55
P,S,T
Tablets
160+800 mg
1.28
P,S,T
Suspension
40+200 mg/5 ml
0.24
P,S,T
Tablets
100 mg
0.94
14th
14th
14th
P,S,T
Syrup
125 mg/5 ml
P,S,T
Tablets
250 mg
P,S,T
Tablets
500 mg
Data not available
P,S,T
Injection
10 mg/ml
Data not available
P,S,T
Injection
40 mg/ml
P,S,T
Tablets
200 mg/100 ml
P,S,T
Tablets
400 mg
P,S,T
Injection
500 mg/100 ml
P,S,T
Syrup
100 mg/5ml
0.16
13th
P,S,T
Tablets
100 mg
6.88
3rd
S,T
Tablets
500 mg
P,S,T
Injection
500 mg
330.60
P,S,T
Injection
1g
514.44
1157 (E)
1157 (E)
1157 (E)
0.92 x(1-27.01%)
28.04.2014
28.04.2014
28.04.2014
56.43%
36.19%
54.23%
55.10%
50.83%
11.30%
6.67%
42.66%
43.09%
5.27%
5.98%
4.55%
1.22%
28.04.2014
42.68%
02.04.2014
28.06.2013
0.00
27.57%
14.6.2013
14.6.2013
27.37%
15.10%
Data not available
14th
1157 (E)
Data not available
Data not available
Data not available
1012(E)
1885
Under consideration
1st
1st
1579
1580
Average
% Reduction w.r.
t. Highest Price
Data not available
2.18
0.67
Price per
Unit
PTR
100.00%
27.01%
19.93
1.33
WPI @ 6.32%
S.No.
0.11
0.78
0.05
0.83
S.O. 2360(E) dt. 15.9.2014
Pack Size
27.0.8.3
Pack Description
BRANDS
Company
Strength
Vitamin A Injection 50000 IU/ml
AQUASOL-A INJ IM. AMP 50 K 2 ML x 1 (/1ML)
AQUASOL-A
USV
50000
MAT Value as on
30th Sept. 2013
Unit
2ML
MAT %
1140794
Price per
Unit
PTR
100.00%
2.84
1.42
1140794
Monopoly situation as M/s USV is the only company manufacturing the formulation and has market share of 100%
PTR per unit
1.42
Section: 27 – Vitamins and Minerals
Medicines
Category
Dosage Form
Strengths
Ascorbic Acid
P,S,T
Tablets
100 mg
Data not ava
3
Ascorbic Acid
Calcium carbonate
P,S,T
P,S,T
Tablets
Tablets
500 mg
250 mg
Data not ava
1.68
7th
2867(E)
20.09.2013
18.45%
4
Calcium carbonate
P,S,T
Tablets
500 mg
1.67
5th
2255 (E)
22.07.2013
24.33%
5
Multivitamins (As per Schedule V of Drugs and
Cosmetics Rules)
P,S,T
Tablets
6
Nicotinamide
P,S,T
Tablets
50 mg
Data not ava
7
Pyridoxine
P,S,T
Tablets
25 mg
Data not ava
8
Riboflavin
P,S,T
Tablets
5 mg
Data not ava
9
Thiamine
P,S,T
Tablets
100 mg
Data not ava
10
Vitamin A
Vitamin A
P,S,T
Tablets
5000 IU
Data not ava
P,S,T
Capsules
50000 IU
Data not ava
P,S,T
100000 IU
Data not ava
13
Vitamin A
Vitamin A
P,S,T
Injection
50000 IU/ml
14
Vitamin D (Ergocalciferol)
P,S,T
Capsules
0.25 mg
Data not ava
15
P,S,T
Capsules
1 mg
Data not ava
Injection
100mg/ml in 10 ml Ampoule
7th
2868 (E)
20.09.2013
35.67%
1
2
11
12
MRP excl. local
taxes (Rs./unit)
Meeting No.
S.O No
% Reduction w.r.
t. Highest Price
Date
Data not ava
Capsules
Under consi
Added Medicines
Calcium Gluconae
16
P,S,T
9.95
Average Reduction
1.42 X (1-26.15%)
26.15%
1.05
0.17
1.22
0.08
1.30 S.O. 2360(E) dt. 15.9.2014
Source of Data-IMS and Pharma trac ( Sep, 2013)
S.No.
Composition of the formulation
Prednisolone
1
ALCON-PRED EYE DROPS 1 % 5 ML x 1
2
PRED FORTE OPHTH.SUSP. 1 % 10 ML x 1
3
4
PREDLY 1% EYE DROPS 5 ML
MAT Units
MAT Value
MAT %
Ceiling Price
with 16 %
Margin
Dosage Form
ALCON
Drops
5
85,626
8.70
4,280,711
4.05%
Drops
10
1,114,318
74.39
82,894,102
78.51%
7.44
Drops
10
2,443
13.20
32,248
0.03%
1.32
INDSWIFT LABORATORIES LTD.
Drops
5
1,757
8.70
57,416
0.05%
1.74
0.02%
1.74
ALLERGAN
PREDNISOLONE ACET. OPHTH.SUSP. 1 % 10 ML x ALLERGAN
Pack Size (In Ml)
Price to Retailer
(Rs.)
Company
Price per ml
1.74
5
RENISONE EYE DROPS 1 % 5 ML x 1
INTAS
Drops
5
975
8.70
22,893
6
PRESOLON EYE DROPS 1 % 5 ML x 1
KLAR SEHEN
Drops
5
14,038
8.70
356,988
0.34%
1.74
7
NAYANPRED EYE DROPS 1 % 5 ML x 1
KLAR SEHEN
Drops
5
858
8.70
17,538
0.02%
1.74
8
PREDACE EYE DROPS 1 % 5 ML x 1
MICRO LABS
Drops
5
10,376
8.70
250,996
0.24%
1.74
99,951
11,228,642
0.09%
10.63%
1.74
1.74
9
PDN EYE DROPS 1 % 5 ML x 1
OPTHO REMEDIES
Drops
5
3,628
10
PREDMET OPHTH.SUSP. 1 % 5 ML x 1
Drops
5
352,769
8.70
8.70
11
PREDMET OPHTH.SUSP. 1 % 10 ML x 1
SUN PHARMA
SUN PHARMA
Drops
10
460,383
13.74
12
PREDNIN-A OPHTH.SOLUT 1 % 5 ML x 1
SUNWAYS
Drops
5
620
8.70
5.99%
1.37
16,691
0.02%
1.74
105,583,559
6,325,383
100.00%
2.72
Maximum
Ceiling Price
MRP (without local taxes)
WPI factor @ 6.32%
Revised Ceiling Price
(including WPI but without local taxes)
Unique
No. as
per
NLEM
3.16
7.44Minimum
1.32
1047.61(Rs. in Lakhs)
13.61
5.00
2.72
0.44
3.16
63.41%
0.2
3.36S.O. 2360(
Company
ACICON
ALEMBIC
20
14TABS
1285723
1.62%
2.50
0.18
FACID FILM C.TABS 20 MG x 14
FACID
INTAS PHA
20
14TABS
2564249
3.23%
2.38
0.17
Famotidine Tablets 20 mg
FADINE TAB UNCOATED 20 MG x 14
FADINE
ARISTO PH
20
14TABS
7173977
9.03%
1.73
0.12
FAMOCID FILM C.TABS 20 MG x 14
FAMOCID
SUN*
20
14TABS
21985123
27.68%
2.66
0.19
FAMONEXT TAB UNCOATED 20 MG x 14
FAMONEXT
CADILA PH
20
14TABS
1612777
2.03%
2.50
0.18
FAMOTIDINE TABS 20 MG x 14
FAMOTIDINE
CADILA PH
20
14TABS
77466
0.10%
2.45
0.18
FAMTAC TAB GELA.COA 20 MG x 14
FAMTAC
ABBOTT*
20
14TABS
10700000
13.47%
9.31
0.67
FM TAB UNCOATED 20 MG x 14
FM
CAPLET IN
20
14TABS
1698864
2.14%
2.50
0.18
Unit
PTR
BRANDS
ACICON FILM C.TABS 20 MG x 14
Pack Size
Ceiling
Price with
Price per 16%
Unit
Margin
Pack Description
17.1.5. Famotidine Tablets 20 mg
Strength
MAT Value as on
MAT %
30th Sept. 2013
TOPCID FILM C.TABS 20 MG x 14
TORRENT
TOPCID
20
14TABS
32339973
40.71%
79438152
100.00%
maximum
2.62
As per the above there are 8 companies consisting of Market Share of 1 % & above
(Rs. in lakhs)
794.38
2.06
9
Average PTR
0.23
0.04
Ceiling price
0.27
65.67%
6.32%
0.29S.O. 2366(E) dt. 15.9.2014
Source of Data-Companies data July, 2013
S.No.
Composition of the Product
Brand Name
Company
GUDCEF -AZ Tablet
Lifestar Pharma Private Ltd.
Tablet
10
152.38
68,000,000
23.27%
15.24
Azibact-CF
Each film coated tablet contains:
Cefpodoxime Proxetil
Eq. to Cefpodoxime IP 200 mg
Azithromycin Dihydrate
Eq. to Azithromycin Anhydrous IP 250 mg q.s
Excipients
Approved Colour used
Kefpod-AZ 250 mg
Glenmark Pharmaceuticals Limited
Tablet
10
151.62
65,323,000
22.36%
15.16
Macpod AZ
1
Dosage Form
Pack size
Price to
Retailer (Rs.)
MAT Value
MAT %
Price per
tablet
Macleods Pharmaceuticals Limited
Tablet
10
153.21
71,100,000
24.33%
15.32
Zedocef AZ
Macleods Pharmaceuticals Limited
Tablet
10
153.21
29,600,000
10.13%
15.32
GUDCEF -AZ Tablet
Mankind Pharmaceuticals ltd.
Tablet
10
152.38
57,788,134
19.78%
15.24
Hetero Healthcare Ltd.
Tablet
10
153.21
376,437
0.13%
15.32
292,187,571
Maximum
100.00%
15.26
As per the above there are 4 companies c
Sum of MAT value considered for price cal
Sum of PTR per unit considered for price c
Average PTR
% Reduction with compared to Highest Pri
15.32Minimum
76.28
5
15.26
2.44
17.70S.O. 2361(E) dt.
0.39%
Source of Data-IMS( Dec, 2013)
S.No.
1
Brand Name
Metformin HCL SR Tablets
Each uncoated sustained release tablet
contains:
Metformin Hydrochloride IP 750 mg
Company
Dosage Form
Strides Arcolab
Tablet
Monopoly situation as only M/s. Str
PTR per unit
Price fixed in the relevant sub-secti
Pack size
Price to
Retailer (Rs.)
30
87.20
MAT Value
2,180
MAT %
0.96%
Price per
tablet
2.91
2.91
18.5: Medicines used in Diabetes mellitus
18.5.1: Insulins and other Antidiabetic agents
1
Medicines
Category
Route of Administration/ Dosage
Form
Strengths
Metformin
P, S, T
Tablets
500 mg
Unit Ceiling Price (Rs.) Meeting No.
1.56
2nd
2.91x(1-41.56%)
S.O. No.
1814
Date
21.6.2013
Average
Reduction
% Reduction
w.r.t. Highest
Price
41.56
41.56
1.70
Retail Price per unit
0.27
1.97 S.O. 2363(
Source of Data-Pharma Trac data Dec, 2013
S.No.
Brand Name
Company
Dosage Form
Pack size
Price to Retailer
(Rs.)
MAT Value
MAT %
Price per capsule
0.19
0.23
0.67 minimum
Retail Price
with 16 %
Margin
17.70
15.16
0.12
0.27
Parvon -Spas Plus
Each capsule contains:
Tramadol Hydrochloride IP 50 mg,
Dicyclomine Hydrochloride IP 10 mg,
Acetaminophen IP 325 mg
1
Spasmo Proxyvon Plus
Wockhardt Ltd.
Capsule
8
Monopoly situation as only M/s. Wockhardt is t
PTR per unit
281,807,978
24.37
100.00%
3.05
3.05
Section: 2 - Analgesics , Antipyretics, Nonsteroidal Anti-inflammatory Medicines, Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders
2.1: Non-Opioid Analgesics, Antipyretics and Nonsteroidal Anti-inflammatory Medicines
Medicines
Category
P, S, T
Strengths
Unit Ceiling Price (Rs.)
Meeting No.
S.O. No.
Date
9th
11th
1st
9th
9th
3567(E)
421(E)
1555(E)
3568(E)
3569(E)
02.12.2013
17.02.2014
14.6.2013
02.12.2013
02.12.2013
% Reduction w.r.t.
Highest Price
Injection
150 mg/ml
Paracetamol
P, S, T
Syrup
125 mg / 5ml
Paracetamol
P, S, T
Tablets
500 mg
Paracetamol
P, S, T
Suppository
80 mg
Paracetamol
P, S, T
Added medicines
S,T
Suppository
170 mg
3.43
0.32
0.94
6.96
8.07
50 mg
6.03
16th
1788(E)
10.07.2014
26.24%
10 mg
10 mg/ml
No Data
2.95
4th
2064(E)
05.07.2013
Average
Reduction
35.20%
Paracetamol
Tramadol
Dicyclomine Hydrochloride
Dicyclomine Hydrochloride
P,S,T
P,S,T
Capsule
17.4: Antispasmodic medicines
Tablets
Injection
3.05 X (1-35.20%)
22.31%
30.00%
56.97%
28.45%
16.98%
65.44%
1.98
0.32
2.30S.O. 2364(E) dt. 15.9.2014
Source of Data-Company ( Sep, 2013)
S.No. Composition of the Product
Brand Name
1
Company
Glycomet GP 0.5
Dosage Form
USV Limited
Pack size
Tablet
Price to
MAT Value
Retailer (Rs.)
10
MAT %
Price per
tablet
34.17 55,700,000 16327.27%
3.42
55,700,000 16327.27%
0.31
Each uncoated bilayered tablet
contains:
Glimepiride IP 0.5 mg
Metformin Hydrochloride IP 500 mg
(As extended release form)
Monopoly situation as only M/s.
PTR per unit
Price fixed in the relevant sub-s
3.42
18.5: Medicines used in Diabetes mellitus
18.5.1: Insulins and other Antidiabetic agents
1
Medicines
Category
Dosage Form
Metformin
P,S,T
Tablets
1.56
S.O. No.
2nd
3.0.6.1
Date
1814
21.6.2013
Average Reduction
41.56
41.56
2.00
0.32
2.32 S.O. 2365(
MAT Value as on
30th Sept. 2013
1
500mg
Unit Ceiling Price (Rs.) Meeting No.
3.42x(1-41.56%)
S.No.
Strengths
%
Reduction w.
r.t. Highest
Price
Pheniramine Maleate Injection 22.75 mg / ml
Pack Description
BRANDS
AVIL INJ AMP 22.7 MG 2 ML x 10 (/1ML)
AVIL INJ AMP 22.7 MG 2 ML x 1 (/1ML)
AVIL INJ VIAL 22.7 MG 10 ML x 1 (/1ML)
INTAVIL INJ AMP 22.7 MG 2 ML x 1 (/1ML)
AVIL
AVIL
AVIL
INTAVIL
Monopoly situation as M/s Sanofi is the only company manufacturing the formulation and has market share
of 99.78%
Average PTR per unit
1.25
Section: 3 – Antiallergics and Medicines used in Anaphylaxis
Strength
Pack Size
22.7
22.7
22.7
22.7
20
2
10
2
Unit
ML
ML
ML
ML
MAT %
220174
75544237
111379608
409121
187553140
Price per
Unit
PTR
0.12%
40.28%
59.39%
0.22%
28.93
2.91
8.27
2.56
1.45
1.46
0.83
1.28
Medicines
Adrenaline Bitartrate
Chlorpheniramine Maleate
Dexchlorpheniramine Maleate
Dexamethasone
Dexamethasone
Hydrocortisone Sodium Succinate
Pheniramine Maleate
Prednisolone
Prednisolone
Prednisolone
Promethazine
Promethazine
Promethazine
Category
P, S, T
P, S, T
P, S, T
P, S, T
P, S, T
P, S, T
P, S, T
P, S, T
P, S, T
P, S, T
P, S, T
P, S, T
P, S, T
Cetrizine
Cetrizine
P, S, T
P, S, T
Route of Admn
Injection
Tablets
Syrup
Tablets
Injection
Injection
Injection
Tablets
Tablets
Tablets
Tablets
Tablets
Syrup/Elixir
Added Medicines
Tablets
Syrup
% Reduction w.r.t.
Date Highest Price
14.06.2013
48.32%
22.07.2013
76.21%
20.09.2013
44.86%
28.04.2014
11.11%
28.04.2014
38.81%
22.07.2013
44.72%
MRP excl. local taxes (Rs./unit)
37.24
0.10
0.30
0.19
2.51
37.13
Monopoly
0.55
0.92
1.72
0.93
2.49
0.21
Meeting No.
1st
5th
7th
14th
14th
5th
S.O No
1565
2232
2831
1157
1157
2233
13th
13th
12th
7th
1st
1st
1008
1009
947
2832
1566
1552
02.04.2014
02.04.2014
27.03.2014
20.09.2013
14.06.2013
14.06.2013
2.08%
4.82%
0.00%
28.00%
12.70%
43.30%
1.81
0.54
3rd
3rd
1875
1876
28.06.2013
28.06.2013
49.14%
56.48%
32.90%
Average Reduction%
1.25 X (1-32.90%)
0.84
0.13
WPI factor @ 6.32%
0.97
0.06
S.No.
1.03S.O. 2360(E) dt. 15.9.2014
Pack Size
13.2.0.7
Strength
MAT Value as on
30th Sept. 2013
Unit
MAT %
Price per
Unit
Pack Description
BRANDS
Silver Sulphadiazine Cream 1%
SILVEZ CREAM 1 % 20 G x 1
SILVEZ
1
20
G
1041855
99.90%
7.53
0.38
SILVA 1% CREAM 20 G
SILVA
1
20
G
180
0.02%
7.60
0.38
SILVERINE 1% CREAM 20 G
SILVERINE
1
20
G
0.08%
7.60
826
1042861
PTR
100.00%Average
0.38
0.38
Monopoly situation as M/s LABORATE PHARMA is the only company manufacturing the formulation and h
PTR per unit
0.38
13.2: Antiinfective medicines
Medicines
Category
Acyclovir
S, T
Route of Admn
Cream
Framycetin Sulphate
P,S,T
Cream
Meeting No.
S.O No
8.88
Data not yet avaibale
2nd
1812
% Reduction w.r.t.
Date Highest Price
21.06.2013
34.22%
Data not yet available
Methylrosanilinium Chloride (Gentian Violet)
P,S,T
Neomycin + Bacitracin
P,S,T
Aqueous solution
Ointment
0.85
17th
2087
20.08.2014
53.75%
Povidone Iodine
P,S,T
Solution
0.39
1st
1651
14.06.2013
69.14%
Povidone Iodine
P,S,T
Ointment
1.64
3rd
1905
28.06.2013
57.89%
Silver Sulphadiazine
P,S,T
Cream
Monopoly
53.75%
Average Reduction
0.38 X (1-53.75%)
0.18
0.03
0.21
WPI factor @ 6.32%
0.01
S.No.
0.22S.O. 2360(E) dt. 15.9.2014
Pack Size
12.2.13.0
Verapamil Tablets 40mg
Pack Description
BRANDS
Strength
CALAPTIN FILM C.TABS 40 MG x 10
CALAPTIN
40
10
114.55
6.52
11.67
20.76
2.27
4.79
3.02
20.51
6.87
1.00
Data not available
Monopoly
Monopoly
Meeting No.
1st
1st
1st
1st
1st
3rd
7th
1st
8th
5th
MAT Value as on
30th Sept. 2013
Unit
MAT %
TABS
45248924
45248924
Monopoly situation as M/s Abbott is the only company manufacturing the formulation and has market share
of 100%
PTR per unit
0.57
12.2: Antiarrhythmic medicines
Medicines
Adenosine
Amiodarone
Amiodarone
Amiodarone
Diltiazem
Diltiazem
Diltiazem
Esmolol
Lignocaine Hydrochloride
Procainamide Hydrochloride
Verapamil
Verapamil
Category
S,T
S,T
S,T
S,T
S,T
S,T
T
T
S,T
S,T
T
T
S,T
S,T
Route of Admn
Injection
Tablets
Tablets
Injection
Tablets
Tablets
Injection
Injection
Injection
Injection
Tablets
Injection
Tablets
Tablets
S.O No
1627
1628
1629
1630
1622
1899
2843
1631
3376
2248
Price per
Unit
PTR
100.00%
% Reduction w.r.t.
Date Highest Price
14.06.2013
39.69%
14.06.2013
16.99%
14.06.2013
20.76%
14.06.2013
23.31%
14.06.2013
33.04%
28.06.2013
46.47%
20.09.2013
39.75%
14.06.2013
11.59%
05.11.2013
49.41%
22.07.2013
49.41%
5.7
0.57
Verapamil
S,T
Injection
Monopoly
33.04%
Average Reduction%
WPI factor @ 6.32%
0.57X (1-33.04%)
0.38
0.06
0.44
0.03
S.No.
0.47S.O. 2360(E) dt. 15.9.2014
Pack Size
12.2.14.0
Verapamil Tablets 80 mg
MAT Value as on
30th Sept. 2013
Pack Description
BRANDS
Strength
CALAPTIN FILM C.TABS 80 MG x 10
CALAPTIN
80
10
Unit
MAT %
Meeting No.
S.O No
114.55
6.52
11.67
20.76
2.27
4.79
3.02
20.51
6.87
1.00
Data not available
0.46
Monopoly Item
Under consideration
1st
1st
1st
1st
1st
3rd
7th
1st
8th
5th
1627
1628
1629
1630
1622
1899
2843
1631
3376
2248
TABS
11735709
11735709
Price per
Unit
PTR
10.9
100.00%
1.09
Monopoly situation as M/s Abbott is the only company manufacturing the formulation and has market share
of 100%
PTR per unit
1.09
Medicines
Category
Adenosine
Amiodarone
Amiodarone
Amiodarone
Diltiazem
Diltiazem
Diltiazem
Esmolol
Verapamil
Verapamil
Verapamil
S,T
S,T
S,T
S,T
S,T
S,T
T
T
S,T
S,T
T
T
S,T
S,T
S,T
Route of Admn
Injection
Tablets
Tablets
Injection
Tablets
Tablets
Injection
Injection
Injection
Injection
Tablets
Injection
Tablets
Tablets
Injection
% Reduction w.r.t.
Date Highest Price
14.06.2013
14.06.2013
14.06.2013
14.06.2013
14.06.2013
28.06.2013
20.09.2013
14.06.2013
05.11.2013
22.07.2013
39.69%
16.99%
20.76%
23.31%
33.04%
46.47%
39.75%
11.59%
49.41%
49.41%
Proposed for 18th AM
33.04%
33.04%
Average Reduction%
WPI factor @ 6.32%
S.No.
1.09 X (1-33.04%)
0.73
0.12
0.85
0.05
0.90S.O. 2360(E) dt. 15.9.2014
Pack Size
12.2.15.0
Verapamil Injection 2.5mg/ml
Pack Description
BRANDS
VPL INJ AMP 2.50 MG 2 ML x 1 (/1ML)
VPL
Strength
MAT Value as on
30th Sept. 2013
Unit
MAT %
2.5 MG
2
ML
20696
20696
Meeting No.
S.O No
114.55
6.52
11.67
20.76
2.27
4.79
3.02
20.51
6.87
1.00
Data not available
Data not available
0.44
0.85
Under Consideration
1st
1st
1st
1st
1st
3rd
7th
1st
8th
5th
1627
1628
1629
1630
1622
1899
2843
1631
3376
2248
Price per
Unit
PTR
1.76
100.00%
0.88
Monopoly situation as M/s Samarth Pharma is the only company manufacturing the formulation and has
market share of 100%
PTR per unit
0.88
Medicines
Category
Adenosine
Amiodarone
Amiodarone
Amiodarone
Diltiazem
Diltiazem
Diltiazem
Esmolol
Verapamil
Verapamil
Verapamil
S,T
S,T
S,T
S,T
S,T
S,T
T
T
S,T
S,T
T
T
S,T
S,T
S,T
Route of Admn
Injection
Tablets
Tablets
Injection
Tablets
Tablets
Injection
Injection
Injection
Injection
Tablets
Injection
Tablets
Tablets
Injection
% Reduction w.r.t.
Date Highest Price
14.06.2013
14.06.2013
14.06.2013
14.06.2013
14.06.2013
28.06.2013
20.09.2013
14.06.2013
05.11.2013
22.07.2013
39.69%
16.99%
20.76%
23.31%
33.04%
46.47%
39.75%
11.59%
49.41%
49.41%
33.04%
33.04%
33.04%
Average Reduction%
WPI factor @ 6.32%
0.88 X (1-33.04%)
0.59
0.09
0.68
0.04
S.No.
0.72S.O. 2360(E) dt. 15.9.2014
MAT Value as on
30th Sept. 2013
2.1.0.1
Acetyl Salicylic Acid Tablets 325 mg
Pack Description
BRANDS
Strength
Pack Size
Unit
ECOSPRIN ENTER C.TABS 325 MG x 14
ECOSPRIN
325
14
TABS
MAT %
8048948
Price per
Unit
PTR
100.00%
7.58
0.54
8048948
Monopoly situation as M/s USV is the only company manufacturing the formulation and has market share of
100%
PTR per unit
2.1: Non-Opioid Analgesics,
Antipyretics
Medicines
0.54
and
Nonsteroidal Anti-inflammatory Medicines
Category
Strengths
MRP excl. local
taxes (Rs./unit) Meeting No.
% Reduction w.
r.t. Highest
Price
S.O NoDate
Under consideration
Acetyl Salicylic Acid
325 mg
P, S, T
1
Acetyl Salicylic Acid
2
3
4
350 mg
Diclofenac
Diclofenac
T
T
Ibuprofen
Data not available
200 mg
1.95
3rd
190928.06.2013
1.49
7th
286920.09.2013
Price Notified in Dec 2013 under DPCO, 1995 in 10th Meeting will be notified in
April 2015
400 mg
Price Notified in Dec 2013 under DPCO, 1995 in 10th Meeting will be notified in
April 2015
50 mg
25 mg / ml
52.64%
70.44%
5
P, S, T
Ibuprofen
6
7
8
9
10
11
12
Ibuprofen
Paracetamol
Paracetamol
Paracetamol
Paracetamol
Paracetamol
0.54 X (1-34.72%)
12th
9th
11th
1st
9th
9th
0.21
3.43
0.32
0.94
6.96
8.07
WPI factor @ 6.32%
0.00%
22.31%
30.00%
56.97%
28.45%
16.98%
Average Reduction%
34.72%
0.44S.O. 2360(E) dt. 15.9.2014
8.3.0.2
94627.03.2014
356702.12.2013
42117.02.2014
155514.06.2013
356802.12.2013
356902.12.2013
0.35
0.06
0.41
0.03
S.No.
100mg/5ml
150 mg / ml
125 mg / 5ml
500 mg
80 mg
170 mg
P, S, T
P, S, T
P, S, T
P, S, T
P, S, T
MAT Value as on
30th Sept. 2013
Pack Description
BRANDS
Prednisolone Injection 20 mg
OMNACORTIL INJ AMP 20 MG 2 ML x 1 (/1ML)
OMNACORTIL
Strength
Pack Size
20
2
Unit
MAT %
ML
133151
Price per
Unit
PTR
7.32
100.00%
3.66
133151
Monopoly situation as M/s Macleods Pharma is the only company manufacturing the formulation
and has market share of 100%
PTR per unit
3.66
8.3: Hormones and antihormones
Medicines
Category
Prednisolone
Prednisolone
Prednisolone
Route of Admn
Tablets
Injection
Injection
S, T
Meeting No.
S.O No
0.55
Under consideration
Data not available
13th
1008
% Reduction w.r.t.
Date Highest Price
02.04.2014
2.08%
Average Reduction%
3.66 X (1-2.08%)
WPI factor @ 6.32%
S.No.
4.41S.O. 2360(E) dt. 15.9.2014
Pack Size
6.2.2.4.1
& 6.5.4
2.08%
3.58
0.57
4.15
0.26
Pack Description
MAT Value as on
30th Sept. 2013
Unit
MAT %
Price per
Unit
BRANDS
Strength
Co-Trimoxazole (Trimethoprim + SulphamethoxaZole)
Tablets 80 + 400 mg
ANTRIMA TABS 400 MG x 10 (/80)
PTR
ANTRIMA
400/80
10TABS
1039856
0.50%
4.50
0.45
Co-Trimoxazole (Trimethoprim + SulphamethoxaZole)
Tablets 80 + 400 mg
SEPTRAN TABS ADULT 400 MG x 10 (/80)
SEPTRAN
400/80
10TABS
207920398
99.50%
5.04
0.50
208960254
100.00%
Monopoly situation as M/s GLAXOSMITHKLINE is the company manufacturing the formulation and has
market share of 99.50%
PTR per unit
0.50
Section: 6 – Anti-infective Medicines
6.2.2 Other Antibacterials
Medicines
Category
Route of
Administration/
Dosage Form
Co-Trimoxazole (Trimethoprim + Sulphamethoxazole) P,S,T
Tablets
Tablets
Suspension
Meeting No.
S.O No
14th
14th
1157(E)
% Reduction w.r.t.
Date Highest Price
Under consideration
1.28
0.24
1157(E)
28.04.2014
28.04.2014
Average Reduction
0.50 X (1-5.27%)
0.47
0.08
0.55
5.98%
4.55%
5.27%
WPI factor @ 6.32%
0.03
0.58S.O. 2360(E) dt. 15.9.2014
Unique
No. as
per
NLEM
17.1.1.1
Pack Description
Aluminium Hydroxide+Magnesium Hydroxide
GELUSIL TABLET 10
BRANDS
GELUSIL TABLET 8
Company
PFIZER LTD
PFIZER LTD
GELUSIL XTRACOOL BLUE 50/250 MG TABLET 10
PFIZER LTD
Pack Size
MAT Value as on
May 2012
Unit
10 Tablet
8 Tablet
10 Tablet
MAT % PTR
18048180
76.41%
7.72
25130
0.11%
7.79
5546806
23620117
23.48%
7.67
100.00%
Price per Unit
0.77
0.97
0.77
0.84
Monopoly situation as M/s Pfizer Ltd is the company manufacturing the formulation and has market share of
100%
PTR per unit
0.84
Section: 17 – Gastrointestinal medicines
17.1: Antacids and other Antiulcer medicines
Medicines
Category
Strengths
Meeting No.
Aluminium Hydroxide + Magnesium Hydroxide
S.O No
% Reduction w.r.
t. Highest Price
Date
Tablet
P,S,T
Aluminium Hydroxide + Magnesium Hydroxide
Suspension
Omeprazole
P,S,T
Omeprazole
Omeprazole
Capsules
10 mg
2nd
Capsules
20 mg
2nd
Capsules
40 mg
8th
Ranitidine
P,S,T
Injection
25 mg / ml
14th
Pantoprazole
T
Injection
40 mg
16th
Famotidine
P,S,T
Tablets
20 mg
13th
1828
1829
3346
1157
21.06.2013
1789
1016
10.07.2014
30.50%
192.11%
17.16%
15.17%
21.06.2013
05.11.2013
28.04.2014
Added Medicines
S.No.
0.84 X (1-52.88%)
WPI factor @ 6.32%
0.40
0.06
0.46
0.03
0.49
31.57%
30.77%
Average
Reduction
52.88%
S.O. 2355(E) dt. 15.9.2014
17.1.1.1
17.1.1.1
17.1.1.1
17.1.1.1
17.1.1.1
17.1.1.1
Pack Description
ZEROCID MPS MINT SYRUP 170 ML
STABIGEL SUSPENSION 170 ML
BRANDS
Manila
Alocid
Concid
Ralcain
Strength
Not specified
Not specified
Not specified
Not specified
Not specified
Not specified
Ceiling Price
Company
SEAGULL
RHOMBUS
Swiss India
Swiss India
Swiss India
Swiss India
Pack Size
WPI factor @ 6.32%
Pack Description
Acetyl Salcylic Acid Tablet 100 mg
COLSPRIN(RECKITT) 100 MG TABLET 14X10
BRANDS
Monopoly situation as M/s Reckitt Benckiser is the company manufacturing the formulation and has market share of 100%
PTR per unit
0.12
Section: 12 - Cardiovascular medicines
12.1 : Antianginal medicines & Section 12.5: Antithrombotic medicines
ML
ML
ML
ML
ML
ML
S.O. 2348(E) dt. 15.9.2014
0.24
12.1.1.2 & 12.5.1.2
MAT Value as on
Price per
May 2012MAT %
PTR
Unit
15528
12.00
0.07
9.80%
1441
41.16
0.24
0.91%
35280
38.22
0.22
22.27%
54411
38.22
0.22
34.34%
33495
38.22
0.22
21.14%
18270
42.12
0.25
11.53%
0.2
158425
100.00%
0.25minimum
maximum
Unit
170
170
170
170
170
170
1.57(Rs. in Lakhs)
0.98
5
0.20
0.03
0.23
20.00%
0.01
S.No.
02.04.2014
Strength
100 MG
Pack Size
Unit
140TABLET
MAT Value as on
Sep 2013MAT %
5001
Price per
Unit
PTR
100%
16.80
0.12
0.23
0.07
Medicines
Category
Strengths
Meeting No.
Acetyl salicylic acid
P,S,T
Tablets
75 mg soulble/dispersible
P,S,T
Tablets
100 mg
P,S,T
Tablets
350 mg
% Reduction w.r.
Date t. Highest Price
S.O No
12th
952(E)
27.03.2014
8.33%
Average Reduction
S.No.
0.12 X (1-8.33%)
WPI factor @ 6.32%
0.11
0.02
0.13
0.01
0.14
8.33%
S.O. 2360(E) dt. 15.9.2014
13.2.2.1
Framycetin Sulphate Cream 0.5%
Pack Description
SOFRAMYCIN 0.5% CREAM 30 GM
BRANDS
Strength
Pack Size
MAT Value as on
Sep 2013MAT %
299353768
Unit
30GM
0.005
19.06
Price per
Unit
0.64
5.65999973
Price per
Unit
5.66
PTR
100%
Monopoly situation as M/s Sofi India Ltd. is the company manufacturing the formulation and has market share of 100%
PTR per unit
0.64
13.2: Antiinfective medicines
Medicines
Acyclovir
Category
S, T
Route of Admn
Cream
Meeting No.
S.O No
8.88
Under consideration
2nd
1812
34.22%
Framycetin Sulphate
P,S,T
Cream
P,S,T
Aqueous solution
Neomycin + Bacitracin
P,S,T
Ointment
0.85
17th
2087
20.08.2014
53.75%
Povidone Iodine
P,S,T
Solution
0.39
1st
1651
14.06.2013
69.14%
Povidone Iodine
P,S,T
Ointment
1.64
3rd
1905
28.06.2013
Silver Sulphadiazine
P,S,T
Cream
0.21
0.64 X (1-53.75%)
Data not available
0.05
0.35
WPI factor @ 6.32%
0.02
53.75%
Average Reduction
53.75%
0.37S.O. 2360(E) dt. 15.9.2014
Cloxacillin 250 mg Injection
57.89%
Proposed for 18th Authority meeting
0.30
6.2.1.8.2.1
% Reduction w.r.t.
Date Highest Price
21.06.2013
Methylrosanilinium Chloride (Gentian Violet)
S.No.
Pack Description
BIOCLOX 250 MG INJECTION 1
BRANDS
Strength
Pack Size
MAT Value as on
Sep 2013MAT %
837731
Unit
1Each pack
PTR
100%
Monopoly situation as M/s Biochem is the company manufacturing the formulation and has market share of 100%
PTR per unit
5.66
6.2 Antibacterials
6.2.1 Beta lactam medicines
Medicines
Cloxacillin
Category
Cloxacillin
Cloxacillin
P,S,T
Cloxacillin
Route of Admn
Capsules
Meeting No.
Data Not available
1.09
Under consideration
Data Not available
Capsules
Injection
Liquid
% Reduction w.r.t.
Date Highest Price
S.O No
Proposed for 18th Meeting
Average Reduction
5.66 X (1-46.59%)
46.59%
3.02
0.48
3.50
WPI factor @ 6.32%
S.No.
46.59%
0.22
3.72S.O. 2360(E) dt. 15.9.2014
6.2.1.8.1.2
Cloxacillin Capsule 500 mg
Pack Description
BIOCLOX 500 MG CAPSULE 10
CLX 500 MG CAPSULE 10
KLOX 500 MG CAPSULE 15
BRANDS
Ceiling Price
Strength
Pack Size
10
10
15
Unit
Capsule
Capsule
Capsule
3.58
2
1.79
0.29
2.08
1.65%
MAT Value as on
30th Sept. 2013 MAT %
14387646
128840
969813
15486298
PTR
92.91%
0.83%
6.26%
100.00%
Maximum
Ceiling
price with
Price per 16%
Unit
Margin
1.76
17.56
18.20
1.82
27.30
1.82
1.79
2.08
1.82 Minimum
1.76
WPI factor @ 6.32%
S.No
0.13
2.21S.O. 2353(E) dt. 15.9.2014
Pack Size
Pack Description
BRANDS
Strength
Carbamazepine Syrup 100mg /5ml
TEGRITAL SYRUP 100 MG 100 ML x 1 (/5ML)
TEGRITAL
100 mg/5ml
MAT Value as on
30th Sept. 2013
Unit
MAT %
Price per
Unit
PTR
5.1.2.3
100ML
19268931
15.40
100.0%
0.15
19268931
Monopoly situation as M/s Novartis Intl is the only company manufacturing the formulation and has market
share of 100%
PTR per unit
0.15
Section: 5 – Anticonvulsants/ Antiepileptics
Medicines
Category
Route of Admn
Carbamazepine
P, S, T
Carbamazepine
Tablets
Carbamazepine
S.No.
Tablets
Syrup
0.15 X (1-25.63%)
Meeting No.
S.O No
13th
1010
02.04.2014
29.41%
1.37
Under Consideration
14th
1157
28.04.2014
21.85%
Average Reduction%
25.63%
0.11
0.02
WPI factor @ 6.32%
0.13
0.01
0.14S.O. 2360(E) dt. 15.9.2014
Pack Size
25.2.2.1
Pack Description
Dextromethorphan
% Reduction w.r.t.
Highest Price
Date
0.70
BRANDS
Strength
DMR 30 MG Tablet 10
30 mg
MAT Value as on
31.05.2012 MAT %
Unit
10
Tablet
235303.4
Price per
Unit
PTR
100.00%
235303
54.22
22.56%Average
5.42
5.42
Monopoly situation as M/s West Coast Pharma Works is the only company manufacturing the formulation
PTR per unit
5.42
25.2: Antitussives
Medicines
Codeine phosphate
Category
S,T
Codeine phosphate
Dextromethorphan
Route of Admn
Tablets
P,S,T
0.92
Syrup
No Data
Tablets
Under Consideration
Meeting No.
S.O No
16th
1782
% Reduction w.r.t.
Highest Price
Date
10.07.2014
13.71%
Average Reduction
WPI factor @ 6.32%
5.42 X (1-13.71%)
5.77S.O. 2358(E) dt. 15.9.2014
Pack Size
27.7.0.1
27.7.0.1
13.71%
4.68
0.75
5.43
0.34
Pack Description
BRANDS
Strength
MAT Value as on
31.05.2012 MAT %
Unit
BENALGIS 100 MG TABLET 10
100 mg
10
Tablet
17056349
100.00%
45.71999995
4.57
Thiamine
THYMINE 100 MG TABLET 10
100 MG
10
Tablet
385
0.00%
38.50
3.85
17056734
1635.57%Average
Monopoly situation as M/s Franco Indian Pharmaceuticals Ltd. is the only company manufacturing the formulation and has market share of 100%
PTR per unit
4.57
Medicines
Ascorbic Acid
Ascorbic Acid
Calcium carbonate
Calcium carbonate
Multivitamins (As per Schedule V of Drugs and
Cosmetics Rules)
Nicotinamide
Category
P,S,T
Route of Admn
Tablets
P,S,T
P,S,T
% Reduction w.r.t.
Highest Price
No data
1.68
7th
2867
20.09.2013
18.45%
1.67
5th
2255
22.07.2013
24.33%
Tablets
No data
No data
P,S,T
Tablets
No data
Tablets
No data
Tablets
Under Consideration
No data
P,S,T
Date
Tablets
P,S,T
Tablets
S.O No
Tablets
Riboflavin
Thiamine
P,S,T
Meeting No.
No data
Tablets
Tablets
P,S,T
Pyridoxine
Vitamin A
Price per
Unit
PTR
Thiamine
Capsules
No data
4.57
No data
P,S,T
Injection
1.3
Capsules
No data
Capsules
No data
Injection
9.95
26.15%
Added Medicines
Calcium Gluconate
P,S,T
7th
2868
20.09.2013
35.67%
Average Reduction
WPI factor @ 6.32%
S.No
4.57 X (1-26.15%)
4.16S.O. 2360(E) dt. 15.9.2014
Pack Size
6.4.2.1.2.2
26.15%
3.37
0.54
3.91
0.25
Pack Description
Didanosine
BRANDS
Strength
DINEX EC 400 MG TABLET 30
MAT Value as on
31.05.2012 MAT %
Unit
400 mg
30
Tablet
4079334
4079334
Price per
Unit
PTR
100.00%
904.9100044
Average
30.16
30.16
Monopoly situation as M/s Cipla Ltd. is the only company manufacturing the formulation and has market share of 100%
PTR per unit
30.16
Medicines
Didanosine
WPI factor @ 6.32%
S.No.
6.2.1.4
Cefotaxime Injection 500 mg
Category
S,T
Route of Admn
Tablet
30.16 X (1-11.73%)
Meeting No.
23.93
S.O No
7th
11.73%
Average Reduction
11.73%
32.83S.O. 2359(E) dt. 15.9.2014
Pack Description
OMNATAX 500 MG INJECTION 2 ML
CEFOTAX 500 MG INJECTION 1
TAXIM 500 MG INJECTION 2 ML
OMNICEF 500 MG INJECTION 2 ML
BIOTAX 500 MG INJECTION 2 ML
Q TAX 500 MG INJECTION 1
CEFAXIL (LEBEN) 500 MG INJECTION 1
CEFLIN (LINCOLN) 500 MG INJECTION 2 ML
CEFANTRAL 500 MG INJECTION 10 ML
CEFENTRAL 500 MG INJECTION 5 ML
SIFOTAXIM 500 MG INJECTION 10 ML
OMINAX 500 MG INJECTION 2 ML
DESATAX 500 MG INJECTION 5 ML
ANTAX(SHRINIVAS) 500 MG INJECTION 1
TROYCEF 500 MG INJECTION 2 ML
C TAX 500 MG INJECTION 1
GENCEF 500 MG INJECTION 1
BRANDS
NLEM
Unique
No.
PACK_DESC
BRANDS
Company
24.1.0.2
24.1.0.2
24.1.0.2
24.1.0.2
24.1.0.2
24.1.0.2
24.1.0.2
24.1.0.2
24.1.0.2
24.1.0.2
24.1.0.2
24.1.0.2
24.1.0.2
24.1.0.2
CEFOTAX INJ DRY VIAL 250 MG x 1
OMNATAX VIAL DRY+SOL 250 MG 2 ML x 1
TAXIM VIAL DRY+SOL 250 MG x 1
OMNICEF INJ DRY VIAL 250 MG x 1
ORITAXIM VIAL DRY+SOL 250 MG x 1
C-TAX INJ DRY VIAL 250 MG x 1
Q-TAX INJ VIAL 250 MG 5 ML x 1
HALTAX INJ DRY VIAL 250 MG x 1
TOX INJ DRY VIAL 250 MG x 1
CEFAXIL INJ DRY VIAL 250 MG x 1
CEFANTRAL VIAL DRY+SOL 250 MG 5 ML
OMINAX INJ DRY VIAL 250 MG x 1
STANCEF INJ DRY VIAL 250 MG x 1
BIOTAX VIAL DRY+SOL 250 MG x 1
CEFOTAX
OMNATAX
TAXIM
OMNICEF
ORITAXIM
C-TAX
Q-TAX
HALTAX
TOX
CEFAXIL
CEFANTRAL
OMINAX
STANCEF
BIOTAX
ABBOTT*
ABBOTT*
ALKEM*
ARISTO PH
CADILA PH
EMCURE*
EMCURE*
HINDUSTAN
LABORATE
LEBEN LAB
LUPIN LIMI
MAPRA LAB
RANBAXY*
ZYDUS CA
% Reduction w.r.t.
Highest Price
20.09.2013
26.62
4.26
30.88
1.95
Company
ABBOTT HEALTHCARE PVT. LTD
ABBOTT HEALTHCARE PVT. LTD
ALKEM LABORATORIES LTD.
ARISTO PHARMACEUTICALS PVT.LTD
BIOCHEM PHARMACEUTICAL INDS
EMCURE PHARMACEUTICALS LTD
LEBEN LABORATORIES PVT.LTD
LINCOLN PHARMACEUTICALS LTD
LUPIN LTD
LUPIN LTD
MANEESH PHARMACEUTICALS LTD
MAPRA LABORATORIES PVT. LTD
SHREYA LIFE SCIENCES PVT. LTD
SHRINIVAS GUJARAT LABORATORIES PVT LTD
TROIKAA PHARMACEUTICALS LTD
ZUVENTUS HEALTHCARE LTD
ZYDUS CADILA
Strength
500 mg
500 mg
500 mg
500 mg
500 mg
500 mg
500 mg
500 mg
500 mg
500 mg
500 mg
500 mg
500 mg
500 mg
500 mg
500 mg
500 mg
Pack Size
UnitMAT Value as on
MAT %
PTR
Each Pack
4043635
0.76%
Each Pack
256405
0.05%
Each Pack
423804094
79.75%
Each Pack
7373658
1.39%
Each Pack
75032452
14.12%
Each Pack
502414
0.09%
Each Pack
609642
0.11%
Each Pack
737278
0.14%
Each Pack
10064799
1.89%
Each Pack
276484
0.05%
Each Pack
76431
0.01%
Each Pack
1580520
0.30%
Each Pack
151032
0.03%
Each Pack
28676
0.01%
Each Pack
74539
0.01%
Each Pack
6602051
1.24%
Each Pack
205134
0.04%
531419245
100.00%
Maximum
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Ceiling Price
WPI factor @ 6.32%
Date
2840(E)
5232
97.54
6
16.26
2.6
18.86
0.18%
1.19
Price per
Ceiling pr
14.68
13.57
16.29
16.29
16.29
16.15
15.86
14.84
16.25
16.13
16.29
15.44
15.7
15.27
16.29
16.29
16.29
16.26
18.86
16.29Minimum
16.13
14.68
13.57
16.29
16.29
16.29
16.15
15.86
14.84
16.25
16.13
16.29
15.44
15.70
15.27
16.29
16.29
16.29
(Rs. in Lakhs)
20.05 S.O. 2350(E) dt. 15.9.2014
Strength
MAT Sep'13
Value
Unit
250
250
250
250
250
250
250
250
250
250
250
250
250
250
1
1
1
1
1
1
1
1
1
1
1
1
1
1
113007
3056523
250495104
5916378
524321
5688567
345804
2652803
558882
325810
6085640
3160403
135943
79593385
MAT%
5060.77%
136879.67%
11217873.00%
264951.99%
23480.56%
254749.98%
15486.07%
118799.96%
25028.30%
14590.69%
272532.02%
141531.71%
6087.91%
3564414.91%
PTR Sep'13
Price per Unit
9.00
11.23
12.35
12.35
9.00
12.35
12.14
12.35
8.25
11.57
12.35
12.03
11.69
12.35
9.00
11.23
12.35
12.35
9.00
12.35
12.14
12.35
8.25
11.57
12.35
12.03
11.69
12.35
Ceiling
Price
with 16%
Margin
358652570
maximum
As per the above there are 5 companies consi
Sum of MAT value considered for price calculat
Sum of PTR per unit considered for price calcul
Average PTR
3,481.25 (Rs. In Lakhs
73.89
6
12.32
1.97
14.29
0.24%
6.32%
15.19S.O. 2350(E) dt. 15.9.2014
16061467.53%
12.35 minimum
12.32
12.14
14.29

Working Sheet Related to Price Notified on 15th

Transcription

Similar documents

NPPA Compendium 2015 - National Pharmaceutical Pricing Authority